Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | BRD-K19103580 | CTRPv2 | pan-cancer | AAC | -0.014 | 0.7 |
mRNA | BIBR-1532 | CTRPv2 | pan-cancer | AAC | -0.014 | 0.7 |
mRNA | BRD1835 | CTRPv2 | pan-cancer | AAC | 0.014 | 0.7 |
mRNA | BRD-K99006945 | CTRPv2 | pan-cancer | AAC | 0.019 | 0.7 |
mRNA | tacrolimus | CTRPv2 | pan-cancer | AAC | -0.013 | 0.7 |
mRNA | BRD-K07442505 | CTRPv2 | pan-cancer | AAC | 0.013 | 0.7 |
mRNA | FK866 | CTRPv2 | pan-cancer | AAC | -0.014 | 0.7 |
mRNA | AM-580 | CTRPv2 | pan-cancer | AAC | 0.013 | 0.7 |
mRNA | N9-isopropylolomoucine | CTRPv2 | pan-cancer | AAC | 0.013 | 0.7 |
mRNA | navitoclax:PLX-4032 (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.012 | 0.7 |